ArticleACS chemical biology2011

Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neurons.

Nigel Ramsden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.